Home  >  Materials, Tools & Resources  >  Education Materials

Patient Education Materials
Physician Clinical and Resource Materials
Video Case Presentations

Patient Education Materials
If You Have Been Diagnosed With Heparin-Induced Thrombocytopenia (ARG169) Questions and answers about heparin and HIT if you or someone you care about are considering surgery.	Download a digital file now Download PDF File (file size: 108 k) or Click the box to order by mail (Packs of 10)
If You Have Been Diagnosed With Heparin-Induced Thrombocytopenia - Spanish (ARG177) Common patient questions and answers on HIT.	Download a digital file now Download PDF File (file size: 95 k) or Click the box to order by mail (Packs of 25)
Physician Clinical and Resource Materials
Delayed-Onset of Heparin-Induced Thrombocytopenia and Thrombosis (ARG171) Warkentin, TE and Kelton, JG. Ann Intern Med. 2001;135:502-506. Author describes a syndrome termed delayed-onset heparin-induced thrombocytopenia, in which thrombocytopenia and thrombotic events begin 5 or more days after withdrawal of heparin.	Click the box to order by mail (Packs of 10)
Argatroban Anticoagulation During Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (ARG058) Lewis et al. Catheterization and Cardiovascular Interventions57:177–184 (2002). Heparin-induced thrombocytopenia (HIT) is an immune-mediated syndrome associated with thrombosis. Alternative anticoagulation to heparin is needed for HIT patients during percutaneous coronary intervention (PCI). We evaluated argatroban, a direct thrombin inhibitor, for anticoagulation in this setting.	View abstract now or Click the box to order the full article by mail (Packs of 10)
Argatroban Anticoagulation in Patients with Heparin-Induced Thrombocytopenia (ARG135) Lewis, et al. Arch Intern Med. 2003;163:1849-1856. HIT is an intensely prothrombotic syndrome managed by discontinuation of heparin therapy and treatment with an alternative inhibitor of thrombin. We describe our experience with argatroban, a direct thrombin inhibitor, in patients with HIT or HIT with thrombosis (HITTS).	View abstract now or Click the box to order the full article by mail (Packs of 10)
HIT Myths and Misconceptions (ARG218) Rice L. Arch Intern Med;164:1961-1964. A discussion of the myths and misconceptions about HIT that “will cause trouble for you and your patients.”	View abstract now or Click the box to order the full article by mail (Packs of 10)
Argatroban Dosing in Patients with Heparin-Induced Thrombocytopenia (ARG193) Verme-Gibboney CN, Hursting MJ. Ann Pharmacother 2003;37:970-5. Authors evaluated clinical experiences with argatroban dosing, particularly incremental dosage adjustments, during a clinical trial of argatroban anticoagulation in HIT.	View abstract now or Click the box to order the full article by mail (Packs of 10)
Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia (ARG108) Lewis et al. Circulation:103:14;1838-1843. Heparin-induced thrombocytopenia (HIT) is an immune-mediated syndrome caused by heparin with serious complications. We report a prospective, historical-controlled study evaluating the efficacy and safety of argatroban, a direct thrombin inhibitor, as anticoagulant therapy in patients with HIT or HIT with thrombosis syndrome (HITTS).	View abstract now or Click the box to order the full article by mail (Packs of 10)
Delayed-Onset of Heparin-Induced Thrombocytopenia (ARG172) Rice L, et al. Ann Intern Med. 2002;136:210-215. Author describes several clinical scenarios when the onset or manifestations of heparin-induced thrombocytopenia were delayed.	Click the box to order by mail (Packs of 10)
Treatment of Heparin-Induced Thrombocytopenia (ARG174) Hirsh J, et al. Arch Intern Med. 2004;164:361-369. This systematic review summarizes the risk for thrombosis in HIT patients when heparin therapy is stopped; evidence of the efficacy of thrombin inhibitors in patients with HIT with and without thrombosis; evidence supporting the use of thrombin inhibitors in patients with a history of HIT who require a coronary intervention procedure; and the risk for bleeding when antithrombotic agents are used.	View abstract now or Click the box to order the full article by mail (Packs of 10)
Heparin-Induced Thrombocytopenia: One Case at A Time - VHS (ARG228) In this video, leading clinicians discuss heparin-induced thrombocytopenia through a series of patient case presentations in a variety of hospital settings and utilizing todays most relevant literature and treatment recommendations. View sample clips Hematology Case Presentation Critical Care Medicine Case Presentation Interventional Cardiology Case Presentation Pharmacy Case Presentation Intensivist/Hospitalist Case Presentation Emergency Medicine Case Presentation	Click the box to order by mail
Heparin-Induced Thrombocytopenia: One Case at A Time - DVD (ARG227) In this video, leading clinicians discuss heparin-induced thrombocytopenia through a series of patient case presentations in a variety of hospital settings and utilizing todays most relevant literature and treatment recommendations. View sample clips Hematology Case Presentation Critical Care Medicine Case Presentation Interventional Cardiology Case Presentation Pharmacy Case Presentation Intensivist/Hospitalist Case Presentation Emergency Medicine Case Presentation	Click the box to order by mail
The Argatroban.com Web site contains links to third-party Web sites on the Internet. These links are provided as a service to individuals interested in more information in HIT. These sites are not part of this GlaxoSmithKline (GSK) Web site. The content and materials in these third-party Web sites are not produced or endorsed by GSK and may refer to uses of our products that are not recommended by GSK.